Stubbs et al - TMAO and CV Outcomes in EVOLVE_CJASN.pdf

Stubbs, Jason; Stedman, Margaret; Liu, Sai; Long, Jin; Franchetti, Yoko; West III, Raymond; Prokopienko, Alex; Mahnken, Jonathan; Chertow, Glenn; Nolin, Tom

doi:10.25376/hra.7845242.v1

Stubbs et al - TMAO and CV Outcomes in EVOLVE_CJASN.pdf (541.32 kB)

Stubbs et al - TMAO and CV Outcomes in EVOLVE_CJASN.pdf

journal contribution

posted on 2019-03-14, 17:33 authored by Jason Stubbs, Margaret Stedman, Sai Liu, Jin Long, Yoko Franchetti, Raymond West III, Alex Prokopienko, Jonathan Mahnken, Glenn Chertow, Tom Nolin

The data demonstrates that baseline levels of TMAO, a circulating compound derived from byproducts of intestinal bacteria, do not predict cardiovascular endpoints in patients with end-stage kidney disease.